(SPXX) Nuveen SP500 Dynamic - Overview
Fund: Stocks, Options, S&P500, Large-Cap
Dividends
| Dividend Yield | 7.76% |
| Yield on Cost 5y | 12.34% |
| Yield CAGR 5y | 8.38% |
| Payout Consistency | 94.2% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 12.3% |
| Relative Tail Risk | 6.37% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.22 |
| Alpha | -6.54 |
| Character TTM | |
|---|---|
| Beta | 0.814 |
| Beta Downside | 0.820 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.64% |
| CAGR/Max DD | 0.69 |
Description: SPXX Nuveen SP500 Dynamic January 01, 2026
The Nuveen S&P 500 Dynamic Overwrite Fund (NYSE: SPXX) is a U.S.-based derivative-income fund that seeks to enhance returns by writing (selling) options against the S&P 500 index. Its ticker is SPXX and it is classified as a fund rather than an ETF, with a primary focus on generating income through option premiums while maintaining exposure to the broad U.S. equity market.
Key operating metrics (as of the most recent quarter) include an expense ratio of roughly 0.75% and an average portfolio turnover of about 30 % annually, reflecting a moderately active options-writing strategy. The fund’s performance is closely tied to two macro drivers: (1) the level of implied volatility in the S&P 500 (30-day VIX ≈ 12 % in early 2024) which determines option premium income, and (2) the Federal Reserve’s monetary-policy stance, as tighter policy can compress equity valuations and affect the upside capture of the underlying index. Sector-wise, the fund tends to overweight defensive sectors (e.g., consumer staples and health care) to mitigate downside risk while still participating in the broader market rally.
If you want a deeper, data-driven view of how SPXX’s option-overlay compares to peers, the ValueRay platform offers granular analytics that can help you quantify the trade-off between premium yield and downside protection.
What is the price of SPXX shares?
Over the past week, the price has changed by +0.00%, over one month by -1.97%, over three months by +4.32% and over the past year by +6.66%.
Is SPXX a buy, sell or hold?
What are the forecasts/targets for the SPXX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 20.9 | 16.6% |
SPXX Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 195.7m USD (195.7m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 195.7m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 195.7m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.91% (E(195.7m)/V(195.7m) * Re(8.91%) + (debt-free company))
Discount Rate = 8.91% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)